NEW HYDROXYCLOROQUINE TRIAL!!! JUST ANNOUNCED
https://www.physiciansweekly.com/launch-of-covid-19-pep-clinical-trial/
Launch Announcement: COVID-19 PEP Clinical Trial
Posted by Physicians Weekly | Mar 31, 2020
The benefits of hydroxychloroquine being investigated in multi-site clinical trial launching in April.
Researchers are investigating whether hydroxychloroquine, a commonly used anti-malarial and autoimmune-disease treatment, can prevent COVID-19.
A multi-site clinical trial, led by the University of Washington School of Medicine in collaboration with New York University Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.
“We currently don’t know if hydroxychloroquine works, but we will learn in as short a timeframe as possible what the outcome is,” said principal investigator Ruanne Barnabas, associate professor of global health in the University of Washington schools of Medicine and Public Health.
Her team is starting to enroll 2,000 participants referred by physicians in six sites who are close contacts of persons with confirmed or pending COVID-19 diagnoses.
Participants will be randomly assigned to take hydroxychloroquine or a placebo over two weeks, and nasal swab samples will be collected and tested daily to confirm new COVID-19 infections across the two groups. Sandoz, a Novartis division, has donated the hydroxychloroquine doses needed to conduct the study.